Search Browse Earnings

PROKIDNEY CORP. — SlamSEC

PROKIDNEY CORP.

Nasdaq:PROK

Biological Products, (No Diagnostic Substances)·WINSTON-SALEM, NC

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2024

Adj. EBITDA

-$150.0M

FY 2024

Net Income

-$35.5M

FY 2024

EPS (Diluted)

-$0.23

FY 2022

Stock Price

$2.46

+3.1%

2026-03-11

52W Range

$0.46 – $7.13

P/E Ratio

-10.7x

Market Cap

—

Cash

$60.6M

FY 2024

Total Debt

—

Net Cash

$60.6M

FY 2024

Enterprise Value

—

Debt / EBITDA

0.4x

FY 2024

EV / EBITDA

—

Employees

—